These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2684394)

  • 1. Decreased accessibility of globotriaosylceramide associated with decreased tumorigenicity in Burkitt's lymphoma variants induced by immunoselection.
    Junqua S; Larsen AK; Wils P; Mishal Z; Wiels J; Le Pecq JB
    Cancer Res; 1989 Dec; 49(23):6480-6. PubMed ID: 2684394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of inhibitory effect of galactose analogs on the binding and cytotoxicity of an anti-globotriaosylceramide monoclonal antibody coupled or not coupled to pokeweed antiviral protein.
    Junqua S; Wils P; Mishal Z; Le Pecq JB
    Eur J Immunol; 1987 Apr; 17(4):459-64. PubMed ID: 2436922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
    Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
    Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines.
    Wiels J; Holmes EH; Cochran N; Tursz T; Hakomori S
    J Biol Chem; 1984 Dec; 259(23):14783-7. PubMed ID: 6438103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant human B cells express two populations of p24 surface antigens.
    Pesando JM; Hoffman P; Conrad T
    J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.
    Mangeney M; Lingwood CA; Taga S; Caillou B; Tursz T; Wiels J
    Cancer Res; 1993 Nov; 53(21):5314-9. PubMed ID: 8221667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.
    Biroccio A; Amodei S; Benassi B; Scarsella M; Cianciulli A; Mottolese M; Del Bufalo D; Leonetti C; Zupi G
    Oncogene; 2002 May; 21(19):3011-9. PubMed ID: 12082531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells.
    Cherney BW; Bhatia KG; Sgadari C; Gutierrez MI; Mostowski H; Pike SE; Gupta G; Magrath IT; Tosato G
    Cancer Res; 1997 Jun; 57(12):2508-15. PubMed ID: 9192833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A monoclonal antibody, specific for Burkitt's lymphoma, is also a blood group Pk antibody].
    Fellous M; Wiels J; Cartron JP; Tursz T
    Dev Biol Stand; 1984; 57():293-8. PubMed ID: 6084615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).
    Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N
    Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody.
    Nudelman E; Kannagi R; Hakomori S; Parsons M; Lipinski M; Wiels J; Fellous M; Tursz T
    Science; 1983 Apr; 220(4596):509-11. PubMed ID: 6836295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc over-expression in Ramos Burkitt's lymphoma cell line predisposes to iron homeostasis disruption in vitro.
    Habel ME; Jung D
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1309-16. PubMed ID: 16466700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of surface antigens during the cell cycle in different growth phases of American and African Burkitt's lymphoma cell lines.
    Sieverts H; Alabaster O; Goldschmidts W; Magrath I
    Cancer Res; 1986 Mar; 46(3):1182-8. PubMed ID: 3080238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
    Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
    Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
    Lavialle C; Modjtahedi N; Cassingena R; Brison O
    Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
    Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
    Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
    Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
    Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-MYC impairs immunogenicity of human B cells.
    Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
    Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.